ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,881.63
      -0.43%
      US Tech 100
      20,449.60
      -0.85%
      Dow Jones
      42,544.22
      -0.07%
      Brent Oil
      73.855
      -1.33%
      Bitcoin
      93,301.55
      -0.09%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Transgene SA (TNG) Quote

      Transgene SA

      Transgene SA (TNG)

      Tng Limited
      Tong Ren Tang Technologies Co
      0.68
      -0.001
      (-0.15%)
      Closed January 01 11:30AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      0.68
      Bid
      0.677
      Ask
      0.683
      Volume
      12,547
      0.677 Day's Range 0.683
      0.656 52 Week Range 1.52
      Market Cap
      68.58M
      Previous Close
      0.681
      Open
      0.681
      Last Trade
      3
      @
      0.68
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      36,352
      Shares Outstanding
      100,852,742
      Dividend Yield
      -
      PE Ratio
      -3.07
      Earnings Per Share (EPS)
      -0.22
      Revenue
      7.9M
      Net Profit
      -22.33M

      About Transgene SA

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.transgene.fr
      Headquarters
      Illkirch-graffenstaden, Bas-rhin, Fra
      Founded
      -
      Transgene SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker TNG. The last closing price for Transgene was 0.68 €. Over the last year, Transgene shares have traded in a share price range of 0.656 € to 1.52 €.

      Transgene currently has 100,852,742 shares outstanding. The market capitalization of Transgene is 68.68 € million. Transgene has a price to earnings ratio (PE ratio) of -3.07.

      Ask ADVFN Intelligence (AI)

      TNG Latest News

      More News

      Transgene et NEC présentent de nouvelles données confirmant la preuve de principe clinique pour son vaccin thérapeutique TG4050, dans les cancers de la tête et du cou au SITC 2024

      Transgene et NEC présentent de nouvelles données confirmant la preuve de principe clinique pour son vaccin thérapeutique TG4050, dans les cancers de la tête et du cou au SITC 2024 Les données de...

      November 07 2024
      UK Regulatory

      Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024

      Compelling 24.1-month median follow-up data presented at SITC 2024 showed that all patients treated with TG4050 after completion of an adjuvant standard of care remain disease-free TG4050 induced...

      November 07 2024
      GlobeNewswire Inc.

      Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024

      Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024 Compelling 24.1-month median follow-up data...

      November 07 2024
      UK Regulatory

      Transgene fait le point sur ses activités, son portefeuille et sa situation financière au troisième trimestre 2024

      Transgene fait le point sur ses activités, son portefeuille et sa situation financière au troisième trimestre 2024 TG4050 : Données prometteuses de Phase I présentées au SITC 2024 confirmant une...

      November 07 2024
      UK Regulatory

      Transgene Reports Business, Pipeline and Financial Update for Q3 2024

      Transgene Reports Business, Pipeline and Financial Update for Q3 2024 TG4050: Promising Phase I data to be presented at SITC 2024 providing clinical proof of principle in adjuvant head and neck...

      November 07 2024
      UK Regulatory

      Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development

      Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development Strasbourg (France), Berlin (Germany), November 5, 2024, 7:30 a.m. CET—Transgene (Euronext Paris: TNG), a...

      November 05 2024
      UK Regulatory

      Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development

      Strasbourg (France), Berlin (Germany), November 5, 2024, 7:30 a.m. CET—Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of...

      November 05 2024
      GlobeNewswire Inc.

      Transgene et ProBioGen collaborent pour faire progresser le développement des vaccins thérapeutiques individualisés

      Transgene et ProBioGen collaborent pour faire progresser le développement des vaccins thérapeutiques individualisés Strasbourg (France), Berlin (Germany), le 5 novembre 2024, 7 h 30 Transgene...

      November 05 2024
      UK Regulatory

      Transgene Provides Update on Phase II Trial of Therapeutic Cancer Vaccine TG4001 in Recurrent or Metastatic HPV16-Positive Cervical and Anogenital Cancers

      Transgene Provides Update on Phase II Trial of Therapeutic Cancer Vaccine TG4001 in Recurrent or Metastatic HPV16-Positive Cervical and Anogenital Cancers Top line data show that the randomized...

      October 14 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.02-2.857142857140.70.7120.656230790.68986025DE
      4-0.023-3.271692745380.7030.80.656261950.72302491DE
      12-0.43-38.73873873871.111.20.656363520.8769892DE
      26-0.324-32.27091633471.0041.210.656284520.96967766DE
      52-0.702-50.79594790161.3821.520.656302211.1217374DE
      156-1.895-73.59223300972.5752.7750.656338521.78366814DE
      260-0.85-55.55555555561.533.150.656729831.98220227DE

      TNG - Frequently Asked Questions (FAQ)

      What is the current Transgene share price?
      The current share price of Transgene is 0.68 €
      How many Transgene shares are in issue?
      Transgene has 100,852,742 shares in issue
      What is the market cap of Transgene?
      The market capitalisation of Transgene is EUR 68.68M
      What is the 1 year trading range for Transgene share price?
      Transgene has traded in the range of 0.656 € to 1.52 € during the past year
      What is the PE ratio of Transgene?
      The price to earnings ratio of Transgene is -3.07
      What is the cash to sales ratio of Transgene?
      The cash to sales ratio of Transgene is 8.68
      What is the reporting currency for Transgene?
      Transgene reports financial results in EUR
      What is the latest annual turnover for Transgene?
      The latest annual turnover of Transgene is EUR 7.9M
      What is the latest annual profit for Transgene?
      The latest annual profit of Transgene is EUR -22.33M
      What is the registered address of Transgene?
      The registered address for Transgene is 400 BOULEVARD GONTHIER D’ANDERNACH-PARC D'INNOVATION, ILLKIRCH-GRAFFENSTADEN, BAS-RHIN, 67405
      What is the Transgene website address?
      The website address for Transgene is www.transgene.fr
      Which industry sector does Transgene operate in?
      Transgene operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BE0945331669ARKimedes Fonds NV
      8.30 €
      (43.10%)
      		125
      ALSAFSAFE
      0.072 €
      (33.58%)
      		267.41k
      IEXIEX Group NV
      2.16 €
      (27.06%)
      		12.41k
      PROACProactis SA
      0.066 €
      (25.71%)
      		216
      ALNN6Enensys
      1.03 €
      (23.80%)
      		118.24k
      EIFDSTour Eiffel DS
      0.006 €
      (-50.00%)
      		257.23k
      MLWEYWeya
      0.013 €
      (-29.73%)
      		150k
      NICBSNicox SA
      0.0131 €
      (-25.99%)
      		10
      ALALOAcheterLouerFR
      0.2221 €
      (-20.65%)
      		5.57k
      SEQUASequana medical NV
      3.06 €
      (-13.07%)
      		623.09k
      ATOAtos SE
      0.0026 €
      (4.00%)
      		555.36M
      ALCYBCybergun
      0.0001 €
      (0.00%)
      		127.25M
      BCPBanco Comercial Portugues SA
      0.4647 €
      (-0.06%)
      		17.83M
      LATLatecoere
      0.0101 €
      (0.00%)
      		15.38M
      EDPEDP SA
      3.091 €
      (-0.26%)
      		6.59M

      Discussion

      View Full Feed
      StockHobit StockHobit 2 minutes ago
      https://www.otcmarkets.com/otcapi/company/financial-report/419820/content
      CEOS
      BrandonSmith1 BrandonSmith1 7 minutes ago
      How many reputable exchanges have listed AURI Token? How much liquidity does the token have? What are the buys? Nothing Burger!!!! Here's your facts below.https://coinranking.com/coin/IJebm1_1+auricoin-auri
      AURI
      nowwhat2 nowwhat2 8 minutes ago
      HNY XRP

      https://investorshub.advfn.com/uimage/uploads/2025/1/1/rzgyzBTC_!_1_CAPT_1215am_HNY_COMP.jpg

      ..................................................................................2025 STARTED PRECISELY AT THAT LEVEL




      .
      XRPUSD
      BrandonSmith1 BrandonSmith1 10 minutes ago
      Total BS. Eddie has nothing. He's living in his sister's house I'm advised. This is pure fraud I believe. Maybe I should send this screenshot to the Wyoming SOS, FBI and SEC?
      AURI
      236T568 236T568 12 minutes ago
      So here is the thing. And, I am not kidding on this one.

      Based on this comment by CNN, shouldn't CNN they describe the Health Insurance CEO murderer as a documented American Citizen?

      https://www.cnn.com/2024/12/31/us/police-identify-victim-in-subway-fire-killing/index
      BrandonSmith1 BrandonSmith1 14 minutes ago
      Did Eddie tell you about Barry Mezey's valid and current UCC lien on Vakser and Auri before Vakscam hired you as a paid promoter? It hasn't worked out so well for Eddie as he can't raise any money from investors or financial institutions. Means your butt is going to be SOL when it comes time to get
      AURI
      BasedOnFeels BasedOnFeels 23 minutes ago
      Emotional, I like it.

      Honeycomb $18k is a promissory note, a loan given for working capital due in 2026. GM was CEO of GRLT so he took the note on behalf of GRLT's assets not his own. Its actually called a "corporate guarantee". Dummy.

      BHG $140k is a promissory note d
      GRLT
      Lakota-45 Lakota-45 24 minutes ago
      I agree with you 'kick Up' - 2024 is in the rear view mirror now, and
      it's looking like we will see both Outdoorsmen & LikeRE
      going public in the 1st qtr of, . . . 2025 !!!

      ~ And like you, "I'm really looking forward to seeing how
      it all rolls out, early, in
      WDLF
      jhnvtjll jhnvtjll 25 minutes ago
      I'm talking about minimal dilution in 2024. You cried about 1M shares added.

      There's minimal dilution.

      Jan 29, 2024 240,265,717
      Feb 9, 2024 240,265,717
      Feb 16, 2024 240,265,717
      Mar 1, 2024 240,865,717
      Mar 8, 2024 240,865,717
      Mar 15, 20
      HWNI
      Telling you there’s a chance Telling you there’s a chance 25 minutes ago
      Is this true Proto? Have you been paid?

      You hurt a lot of people with your nonsense, this is getting ridiculous. I just see that you stretch what they say to fit your narrative , that’s great when your right, but how about when your wrong? How do you feel about what you have done to
      LWLG
      johnydollar johnydollar 29 minutes ago
      Happy new year 🎉 ✨️.........

      2025.....
      DBMM
      borysek borysek 30 minutes ago
      bad situation ...
      WEED
      sharkey1 sharkey1 34 minutes ago
      I’m looking for headlines concerning Purdue

      https://patentlyo.com/patent/2024/12/federal-invalidity-oxycontin.html

      No main stream yet
      ELTP
      Bob Mullet Bob Mullet 46 minutes ago
      Keep posting happy new year best wishes 

      There's still no spider silk on sale since almost TWO decades since the company was formed. 

      People laugh at you

      Keep it up....see you next fatnothingburger year!!!


      KBLB
      stocks2012 stocks2012 58 minutes ago
      Happy NewbYear!
      PLUG
      jimmy051357 jimmy051357 1 hour ago
      Every share reduction in the A/S, increases my share of ownership in #GROO. Right now the effective rate after the R/S will be 1:12.5. Everybody hid behind the 2500 to 1 R/S of the O/S, not taking into account the 200 to 1 reduction of the A/S, saying the world was ending. Things are coming togeth
      SANP
      deepdj011 deepdj011 1 hour ago
      New Year - Good Start! Power Year 2025 
      XRPUSD
      Evaluate Evaluate 1 hour ago
      "Do you need to say more?" .... Sure: please say more.
      Since I do not believe that your reply answers or addresses my question? Here it is again:
      Question: will the more recent announced collaboration with Palantir (PLTR) possibly diminish the extent of the RCAT/PDYN collaboration (sin
      PDYN PLTR RCAT
      QuantumTravesty QuantumTravesty 1 hour ago
      If you take out the extra words none of what’s left is bad.
      1) new providers and
      enhanced communication
      2) strengthening corporate governance audit results.
      3) concluded previous business relationships
      3) developments in the coming
      weeks.
      HIRU
      Argeoz Argeoz 1 hour ago
      https://www.accesswire.com/962239/cecors-announces-leadership-transition-michael-maher-distinguished-veteran-and-leader-named-interim-ceo
      CEOS
      ColdDarkHole ColdDarkHole 1 hour ago
      Happy realistic new year!
      NB
      valeria123 valeria123 1 hour ago
      https://ih.advfn.com/stock-market/USOTC/blue-biofuels-qb-BIOF/stock-news/95178608/form-4-statement-of-changes-in-beneficial-owners
      BIOF
      jjmentat jjmentat 1 hour ago
      HAPPY NEW YEAR!!!!!

      Your Recent History

      EU
      TNG
      Transgene
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads